(6-Fluoroimidazo[1,2-a]pyridin-3-yl)(phenyl)methanone
97%
- Product Code: 113359
CAS:
1634647-80-5
| Molecular Weight: | 240.23 g./mol | Molecular Formula: | C₁₄H₉FN₂O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD28142906 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, dry and sealed |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and drug development. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting neurological and psychiatric disorders. Its structural framework is often incorporated into compounds designed to interact with specific receptors in the brain, such as GABA receptors, which are implicated in conditions like anxiety, insomnia, and epilepsy. Additionally, its fluorine moiety enhances its metabolic stability and bioavailability, making it a valuable component in the creation of potential therapeutic agents. Research efforts also explore its application in developing inhibitors for enzymes involved in disease pathways, further expanding its utility in pharmaceutical innovation.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | €33.00 |
+
-
|
| 0.250 | 10-20 days | €54.61 |
+
-
|
| 1.000 | 10-20 days | €163.59 |
+
-
|
(6-Fluoroimidazo[1,2-a]pyridin-3-yl)(phenyl)methanone
This compound is primarily utilized in the field of medicinal chemistry and drug development. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting neurological and psychiatric disorders. Its structural framework is often incorporated into compounds designed to interact with specific receptors in the brain, such as GABA receptors, which are implicated in conditions like anxiety, insomnia, and epilepsy. Additionally, its fluorine moiety enhances its metabolic stability and bioavailability, making it a valuable component in the creation of potential therapeutic agents. Research efforts also explore its application in developing inhibitors for enzymes involved in disease pathways, further expanding its utility in pharmaceutical innovation.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :